The Portfolio

CardioFocus

CardioFocus is developing a catheter-based approach to treating atrial fibrillation.

Coinvestors include Oxford Biosciences, SV Life Sciences, H.I.G. Ventures, Aurora Funds and KBL Healthcare Ventures.

www.cardiofocus.com

Website design by Art Wave